MoonLake Immunotherapeutics
Trade MoonLake Immunotherapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MLTX
Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases.
MLTX Key Statistics
Stock Snapshot
As of today, MoonLake Immunotherapeutics(MLTX) shares are valued at $9.92. The company's market cap stands at 830.64M, with a P/E ratio of -2.54.
During the trading session on 2026-10-20, MoonLake Immunotherapeutics(MLTX) shares reached a daily high of $9.92 and a low of $9.50. At a current price of $9.92, the stock is +4.4% higher than the low and still 0.0% under the high.
Trading activity shows a volume of 911.74K, compared to an average daily volume of 1.89M.
Over the past 52 weeks, MoonLake Immunotherapeutics(MLTX) stock has traded between a high of $23.29 and a low of $8.90.
Over the past 52 weeks, MoonLake Immunotherapeutics(MLTX) stock has traded between a high of $23.29 and a low of $8.90.
Analyst ratings
73%
of 15 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.